Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews

被引:281
作者
Song, Fujian [1 ]
Loke, Yoon K. [1 ]
Walsh, Tanya [2 ]
Glenny, Anne-Marie [2 ]
Eastwood, Alison J.
Altman, Douglas G. [3 ]
机构
[1] Univ E Anglia, Fac Hlth, Norwich NR4 7TJ, Norfolk, England
[2] Univ Manchester, Sch Dent, Manchester M13 9PL, Lancs, England
[3] Ctr Stat Med, Oxford, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2009年 / 338卷
关键词
MIXED TREATMENT COMPARISONS; ACTIVE-CONTROL TRIALS; COMPETING INTERVENTIONS; CLINICAL-TRIALS; METAANALYSIS; EFFICACY; PLACEBO;
D O I
10.1136/bmj.b1147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To investigate basic assumptions and other methodological problems in the application of indirect comparison in systematic reviews of competing healthcare interventions. Design Survey of published systematic reviews. Inclusion criteria Systematic reviews published between 2000 and 2007 in which an indirect approach had been explicitly used. Data extraction Identified reviews were assessed for comprehensiveness of the literature search, method for indirect comparison, and whether assumptions about similarity and consistency were explicitly mentioned. Results The survey included 88 review reports. In 13 reviews, indirect comparison was informal. Results from different trials were naively compared without using a common control in six reviews. Adjusted indirect comparison was usually done using classic frequentist methods (n=49) or more complex methods (n=18). The key assumption of trial similarity was explicitly mentioned in only 40 of the 88 reviews. The consistency assumption was not explicit in most cases where direct and indirect evidence were compared or combined (18/30). Evidence from head to head comparison trials was not systematically searched for or not included in nine cases. Conclusions Identified methodological problems were an unclear understanding of underlying assumptions, inappropriate search and selection of relevant trials, use of inappropriate or flawed methods, lack of objective and validated methods to assess or improve trial similarity, and inadequate comparison or inappropriate combination of direct and indirect evidence. Adequate understanding of basic assumptions underlying indirect and mixed treatment comparison is crucial to resolve these methodological problems. Appendix 1 PubMed search strategy Appendix 2 Characteristics of identified reports Appendix 3 Identified studies References of included studies
引用
收藏
页码:932 / 935
页数:7
相关论文
共 20 条
[1]   Statistics Notes - Interaction revisited: the difference between two estimates [J].
Altman, DG ;
Bland, JM .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7382) :219-219
[2]   The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials [J].
Bucher, HC ;
Guyatt, GH ;
Griffith, LE ;
Walter, SD .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (06) :683-691
[3]   Simultaneous comparison of multiple treatments: combining direct and indirect evidence [J].
Caldwell, DM ;
Ades, AE ;
Higgins, JPT .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7521) :897-900
[4]   Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses [J].
Chou, Roger ;
Fu, Rongwei ;
Huffman, Laurie Hoyt ;
Korthuis, P. Todd .
LANCET, 2006, 368 (9546) :1503-1515
[5]   THE COMBINATION OF ESTIMATES FROM DIFFERENT EXPERIMENTS [J].
COCHRAN, WG .
BIOMETRICS, 1954, 10 (01) :101-129
[6]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[7]   Active-control trials:: How would a new agent compare with placebo?: A method illustrated clopidogrel, aspirin, and placebo [J].
Fisher, LD ;
Gent, M ;
Büller, HR .
AMERICAN HEART JOURNAL, 2001, 141 (01) :26-32
[8]  
Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1
[9]  
Hasselblad V, 2001, DRUG INF J, V35, P435, DOI 10.1177/009286150103500212
[10]  
Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO